Wenger, T <br/><br/>
Specific resistance upon lentiviral TRAIL transfer by intracellular retention of TRAIL receptors.  [electronic resource] 

 -  Cell death and differentiation  Oct 2006 
 - 1740-51 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1350-9047 
<br/><br/><label>Standard No.: </label>10.1038/sj.cdd.4401867  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>Apoptosis Regulatory Proteins--antagonists & inhibitors<br/>Base Sequence<br/>Cell Line, Tumor<br/>Cisplatin--pharmacology<br/>Death Domain Receptor Signaling Adaptor Proteins<br/>Drug Resistance, Neoplasm<br/>Endoplasmic Reticulum--metabolism<br/>Gene Transfer Techniques<br/>Genetic Therapy--methods<br/>Genetic Vectors<br/>Golgi Apparatus--metabolism<br/>Green Fluorescent Proteins--genetics<br/>Humans<br/>Jurkat Cells<br/>Lentivirus--genetics<br/>Membrane Glycoproteins--antagonists & inhibitors<br/>RNA, Messenger--genetics<br/>RNA, Neoplasm--genetics<br/>RNA, Small Interfering--genetics<br/>Receptors, TNF-Related Apoptosis-Inducing Ligand<br/>Receptors, Tumor Necrosis Factor--genetics<br/>Recombinant Fusion Proteins--genetics<br/>Signal Transduction<br/>TNF-Related Apoptosis-Inducing Ligand<br/>Transduction, Genetic<br/>Tumor Necrosis Factor Receptor-Associated Peptides and Proteins--metabolism<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors